B2M and androgen insensitivity syndrome: As mentioned above, as a biomarker of inflammation, β2M may be the etiological basis of AIS, reflecting the (chronic) inflammatory status in vivo5,10,41, which may be of great predictive significance for AIS, especially if the intervention of β2M could reduce the incidence of AIS.